![](https://cdn.sanity.io/images/0vv8moc6/curetoday/0e2e4ef5a30369910672f2c2212e4c59f599a8cc-7934x5292.jpg?fit=crop&auto=format)
EBRT Regimens Show Long-Term Survival Outcomes in Prostate Cancer
For patients with intermediate-risk prostate cancer (IRPC), external beam radiation therapy (EBRT) with or without short-term neoadjuvant androgen deprivation therapy (STAD) elicited 15-year survival, according to a study presented in a poster session at …